KPRX Kiora Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
KPRX is expected to report earnings to fall 12.07% to -50 cents per share on August 07
Q2'26
Est.
$-0.51
Q1'26
Missed
by $0.09
Q4'25
Missed
by $1.50
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.48
The last earnings report on May 08 showed earnings per share of -57 cents, missing the estimate of -49 cents. With 7.05K shares outstanding, the current market capitalization sits at 10.90M.
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products to treat eye diseases
A.I.dvisor tells us that KPRX and ABVX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and ABVX's prices will move in lockstep.
KPRX's Stochastic Oscillator sits in oversold zone for 2 days
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KPRX as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for KPRX turned negative on July 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
KPRX moved below its 50-day moving average on July 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for KPRX crossed bearishly below the 50-day moving average on July 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for KPRX entered a downward trend on July 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.782) is normal, around the industry mean (22.885). P/E Ratio (3.670) is within average values for comparable stocks, (37.796). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.508). KPRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (0.823) is also within normal values, averaging (434.181).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. KPRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
